* USANA Health Sciences Inc USNA.N reported quarterly adjusted
earnings of $1.36 per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for earnings of $1.30 per share.
* Revenue fell 8.1% to $274.35 million from a year ago;
analysts expected $268.07 million.
* USANA Health Sciences Inc's reported EPS for the quarter was
$1.36.
* The mean earnings estimate of analysts had fallen by
about 14.2% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* USANA Health Sciences Inc shares had risen by 8.2% this
quarter and gained 29.4% so far this year.
* The company reported quarterly net income of $27.33 million.
* Wall Street's median 12-month price target for USANA Health
Sciences Inc is $100.00
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated October 27 at 09:50 a.m.
All figures in US dollars unless otherwise stated